The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Fluoxetine in Early Poststroke Depression: A Double-Blind Placebo-Controlled Study
Abstract
Background and Purpose —Early poststroke depression (PSD) is a frequent and specific entity that impairs the rehabilitation and functional recovery of hemiplegic patients. This trial was designed to study the efficacy and tolerance of fluoxetine (FLX) in the treatment of early PSD. Methods —This was a multicenter, double-blind, placebo-controlled study. Recent hemiplegic patients (<3 months) suffering from major depressive disorder (determined by International Classification of Diseases, 10th Revision, and Montgomery-Asberg Depression Rating Scale [MADRS] >19) were randomized to receive either 20 mg/d fluoxetine (FLX) or placebo for 6 weeks. Patients were evaluated by use of the Motricity Index, Mini-Mental State Examination, Functional Independence Measure, and MADRS. Statistical analysis was performed by using an intent-to-treat approach comparing the 2 groups at day 0 (baseline) and days 15, 30, and 45 (end point). Results —Of 121 patients screened, 31 were included in the study, 16 in the FLX group and 15 in the placebo group. There were no significant differences in baseline characteristics among the 2 groups. The FLX-treated patients compared with placebo-treated patients demonstrated significant improvement in mean MADRS scores at end point (11.8±6.7 [mean±SD] versus 18.7±10.0, respectively; P =0.05). FLX-treated patients compared with placebo-treated patients also demonstrated greater response rate (62.5% versus 33.3%, respectively) and greater mean decrease of MADRS (16.6 versus 8.4, respectively; P =0.02). There were no differences in motor, cognitive, or functional improvement and no significant side effects after FLX treatment, except for a patient with a moderate and transient increase of transaminases. Conclusions —FLX is an efficacious and well-tolerated treatment for early PSD. Further research is needed to evaluate the efficacy and safety of long-term treatment in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Interrater reliability of the 7-level functional independence measure (FIM)
Dickson, H., & Köhler, F. (2020) · Journal of Rehabilitation Medicine · doi:10.2340/165019779527253256 · Cited by 576
Post-stroke depressive disorders: a follow-up study of 103 patients.
Robinson, R. G., & Price, T. R. (1982) · Stroke · doi:10.1161/01.str.13.5.635 · Cited by 564
Interrater reliability of the 7-level functional independence measure (FIM)
Hamilton, B., Laughlin, J., Fiedler, R., & Cv, G. (1994) · Journal of Rehabilitation Medicine · doi:10.2340/165019771994263115119 · Cited by 544
NORTRIPTYLINE TREATMENT OF POST-STROKE DEPRESSION: A DOUBLE-BLIND STUDY
Lipsey, J., Pearlson, G., Robinson, R., Rao, K., & Price, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90356-8 · Cited by 539
Parikh, R. M., Robinson, R. G., Lipsey, J. R., Starkstein, S. E., Fedoroff, J. P., & Price, T. R. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530070083014 · Cited by 495
Association of depression with 10-year poststroke mortality
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.124 · Cited by 472
Andersen, G., Vestergaard, K., & Lauritzen, L. (1994) · Stroke · doi:10.1161/01.str.25.6.1099 · Cited by 378
Dam, M., Tonin, P., De Boni, A., Pizzolato, G., Casson, S., Ermani, M., Freo, U., Piron, L., & Battistin, L. (1996) · Stroke · doi:10.1161/01.str.27.7.1211 · Cited by 347
Cited by
Post-Stroke Depression: A Review
Robinson, R. G., & Jorge, R. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030363 · Cited by 1,125
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Management of Adult Stroke Rehabilitation Care: A Clinical Practice Guideline
Duncan, P. W., Zorowitz, R., Bates, B., Choi, J. Y., Glasberg, J. J., Graham, G. D., Katz, R. C., Lamberty, K., & Reker, D. (2005) · Stroke · doi:10.1161/01.str.0000180861.54180.ff · Cited by 1,046
Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70314-8 · Cited by 925
Post stroke depression: epidemiology, pathophysiology, and biological treatment
Whyte, E. M., & Mulsant, B. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01424-5 · Cited by 488
Metadata
- Authors
- Wiart, L., Petit, H., Joseph, P. A., Mazaux, J. M., & Barat, M.
- Venue
- Stroke
- Published
- 2000-08
- Volume
- 31
- Issue
- 8
- Pages
- 1829-1832
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2112642129
- Cited by
- 261
- References
- 24
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoxetine in Early Poststroke Depression: A Double-Blind Placebo-Controlled Study. https://app.cochat.ai/papers/10.1161/01.str.31.8.1829
- The paper
- Wiart, L., Petit, H., Joseph, P. A., Mazaux, J. M., & Barat, M. (2000). Fluoxetine in Early Poststroke Depression: A Double-Blind Placebo-Controlled Study. Stroke. https://doi.org/10.1161/01.str.31.8.1829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.